Dubois B, Slachevsky A, Litvan I, Pillon B
INSERM EPI 007 and Fédération de Neurologie (Drs. Dubois, Slachevsky, and Pillon), Hôpital de la Salpêtrière, Paris, France.
Neurology. 2000 Dec 12;55(11):1621-6. doi: 10.1212/wnl.55.11.1621.
To devise a short bedside cognitive and behavioral battery to assess frontal lobe functions.
The designed battery consists of six subtests exploring the following: conceptualization, mental flexibility, motor programming, sensitivity to interference, inhibitory control, and environmental autonomy. It takes approximately 10 minutes to administer. The authors studied 42 normal subjects and 121 patients with various degrees of frontal lobe dysfunction (PD, n = 24; multiple system atrophy, n = 6; corticobasal degeneration, n = 21; progressive supranuclear palsy, n = 47; frontotemporal dementia, n = 23).
The Frontal Assessment Battery scores correlated with the Mattis Dementia Rating Scale scores (rho = 0.82, p < 0.01) and with the number of criteria (rho = 0.77, p < 0.01) and perseverative errors (rho = 0.68, p < 0.01) of the Wisconsin Card Sorting Test. These variables accounted for 79% of the variance in a stepwise multiple regression, whereas age or Mini-Mental State Examination scores had no significant influence. There was good interrater reliability (kappa = 0.87, p < 0.001), internal consistency (Cronbach's coefficient alpha = 0.78), and discriminant validity (89.1% of cases correctly identified in a discriminant analysis of patients and controls).
The Frontal Assessment Battery is easy to administer at bedside and is sensitive to frontal lobe dysfunction.
设计一套简短的床边认知与行为测试组合,以评估额叶功能。
所设计的测试组合包含六个子测试,用于探究以下方面:概念形成、心理灵活性、运动编程、对干扰的敏感性、抑制控制以及环境自主性。测试实施大约需要10分钟。作者研究了42名正常受试者以及121名患有不同程度额叶功能障碍的患者(帕金森病,n = 24;多系统萎缩,n = 6;皮质基底节变性,n = 21;进行性核上性麻痹,n = 47;额颞叶痴呆,n = 23)。
额叶评估测试组合得分与马蒂斯痴呆评定量表得分(rho = 0.82,p < 0.01)以及威斯康星卡片分类测试的标准数量(rho = 0.77,p < 0.01)和持续性错误(rho = 0.68,p < 0.01)相关。在逐步多元回归中,这些变量解释了79%的方差变异,而年龄或简易精神状态检查得分无显著影响。评分者间信度良好(kappa = 0.87,p < 0.001),内部一致性(克朗巴赫系数α = 0.78)以及判别效度(在患者与对照的判别分析中,89.1%的病例被正确识别)。
额叶评估测试组合易于在床边实施,且对额叶功能障碍敏感。